The US ischemic stroke market is on an upward trajectory, poised to reach approximately $2.39 billion by 2035, driven by a compound annual growth rate (CAGR) of 7.93%. Recent advancements in medical technologies and a growing emphasis on preventive care strategies are pivotal to this market's expansion. As stroke remains a leading cause of morbidity and mortality in the United States,...